UCL Institute of Neurology
Research and teaching excellence
The Institute of Neurology has a world class reputation for neuroscience. The mission is to translate neuroscience discovery research into treatments for patients with neurological diseases. A number of important research centres are based at the Institute, including the MRC Centre for Neuromuscular Diseases and the Wellcome Centre for Human Neuroimaging
The hub of the research activities and operational headquarters of the UK Dementia Research Institute (DRI) are also at UCL, embedded within the Institute.
Professor Michael Hanna is the Director of the Institute, which is a specialist postgraduate institute of University College London, the top-ranked university in the UK for research in Psychology, Psychiatry and Neuroscience.
The Institute is closely associated in its work with the National Hospital for Neurology & Neurosurgery. In combination they form a national and international centre at Queen Square for teaching, training and research in neurology and allied clinical and basic neurosciences.
What We Do
Please see our Infographic highlighting key data on the Institute.
A team led by UCL and Cardiff University researchers has developed a novel measure of disease progression for Huntington’s disease, which enabled them to identify a genetic modifier associated with how rapidly the disease progresses.
Published: Jun 20, 2017 9:05:51 AM
Bringing a wealth of experience and innovation in neurodegenerative diseases research, Dr Ivinson is currently Executive Director of the Institute for the Neurosciences, and of the Ann Romney Center for Neurologic Diseases, both at Brigham and Women’s Hospital, a Harvard Medical School affiliate.
Published: Jun 16, 2017 12:11:38 PM
first blood test that can predict the onset and progression of
Huntington’s disease has been identified by a UCL-led study.
Published: Jun 8, 2017 10:51:52 AM